Company / CapEx per Share
AbbVie CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.68
FY2025
5-year range
$0.42 / $0.68
FY2021-FY2025
Trend
+25.0%
vs FY2024
Sector context
#16 of 190
Health Care
What the data says
Among 190 Health Care companies, AbbVie is in the top 8% for capex per share. CapEx per Share has increased for 3 consecutive years, from $0.42 in FY2022 to $0.68 in FY2025.
Based on SEC 10-K filings.
0.68 in FY2025 with a 5-year CAGR of +5.8%. Top quartile in the Health Care sector.
Improved from $0.44 to $0.68 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +18.1%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 190This company $0.68 Sector average $2.49
▼
-72.5% below sector average
Key checks
Key Insights
- AbbVie's capex per share has grown for 3 consecutive years.
- In FY2025, capex per share increased 25.0% year-over-year.
- Ranks #16 out of 190 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | +25.0% |
| FY2024 | $0.55 | +25.3% |
| FY2023 | $0.44 | +5.3% |
| FY2022 | $0.42 | -21.7% |
| FY2021 | $0.53 | +2.7% |
| FY2020 | $0.52 | +49.9% |
| FY2019 | $0.34 | -12.0% |
| FY2018 | $0.39 | +21.0% |
| FY2017 | $0.32 | +8.6% |
| FY2016 | $0.30 | -10.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026